Brokerages Set Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Price Target at $22.25

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have been given an average recommendation of “Moderate Buy” by the fourteen analysts that are currently covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $22.25.

SBRA has been the topic of a number of analyst reports. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research report on Thursday, August 6th. Wells Fargo & Company boosted their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Truist Financial increased their price objective on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. Finally, Citigroup restated a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd.

Sabra Healthcare REIT Stock Up 1.7%

Shares of NASDAQ SBRA opened at $20.19 on Thursday. Sabra Healthcare REIT has a 12-month low of $17.17 and a 12-month high of $22.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07. The firm’s 50-day moving average is $19.92 and its two-hundred day moving average is $20.00. The company has a market capitalization of $5.16 billion, a PE ratio of 77.66, a price-to-earnings-growth ratio of 1.53 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.27). The company had revenue of $230.11 million for the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The business’s quarterly revenue was up 24.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.38 EPS. Equities analysts anticipate that Sabra Healthcare REIT will post 1.51 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. Sabra Healthcare REIT’s payout ratio is presently 461.54%.

Institutional Investors Weigh In On Sabra Healthcare REIT

Institutional investors have recently made changes to their positions in the company. PNC Financial Services Group Inc. raised its stake in Sabra Healthcare REIT by 2.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock worth $451,000 after acquiring an additional 528 shares during the period. Larson Financial Group LLC raised its stake in Sabra Healthcare REIT by 42.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 553 shares in the last quarter. Inspire Investing LLC lifted its holdings in Sabra Healthcare REIT by 2.3% in the fourth quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust’s stock worth $469,000 after purchasing an additional 565 shares during the period. Natixis Advisors LLC lifted its stake in shares of Sabra Healthcare REIT by 2.2% in the 3rd quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock worth $516,000 after acquiring an additional 598 shares during the period. Finally, Versant Capital Management Inc lifted its position in Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after purchasing an additional 603 shares during the period. 99.40% of the stock is currently owned by institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.